CAS 1628502-91-9

MW-150

Description:

As of my last update in October 2023, "MW-150" with the CAS number "1628502-91-9" is a chemical compound that has garnered attention in research contexts, particularly in the field of medicinal chemistry. It is characterized by its potential as a therapeutic agent, often investigated for its effects on various biological pathways. The compound may exhibit properties such as selective receptor binding, which could influence its efficacy in treating specific conditions. Additionally, MW-150 is noted for its solubility characteristics, which can affect its bioavailability and pharmacokinetics. Safety profiles, including toxicity and side effects, are critical aspects of its evaluation in preclinical and clinical studies. As with any chemical substance, its handling requires adherence to safety protocols, and its use is subject to regulatory guidelines. For detailed information regarding its specific applications, mechanisms of action, and comprehensive safety data, consulting scientific literature and databases is recommended.

Formula: C₂₄H₂₃N₅

Synonyms:

• Pyridazine, 6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-
• MW-150

6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-pyridazine

CAS: 1628502-91-9

Formula: C₂₄H₂₃N₅

Purity: 97%

Color and Shape: Solid

Molecular weight: 381.4729

Ref: IN-DA01LIB9

MW-150

CAS: 1628502-91-9

MW-150

Purity: ≥95%

Molecular weight: 381.47g/mol

Ref: 54-BUP15069

MW-150

CAS: 1628502-91-9

MW-150 (MW01-18-150SRM) is a unique protein kinase inhibitor, is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM.

Formula: C₂₄H₂₃N₅

Purity: 97.35% - 99.27%

Color and Shape: Solid

Molecular weight: 381.47

Ref: TM-T5494

MW-150

CAS: 1628502-91-9

MW-150 is a monoclonal antibody that binds to the heavy chains of myasthenia gravis autoantibodies. It prevents the binding of these autoantibodies with muscle cells, which inhibits their effect on neuromuscular transmission. MW-150 has also been shown to have an inhibitory effect on intracellular signalling pathways in nerve cells, inhibiting neurotransmitter release and blocking calcium influx into the cell. The drug is injected intramuscularly or intravenously and can be used for long periods of time without any significant side effects. MW-150 has been tested in humans and found to be safe and well tolerated.

Formula: C₂₄H₂₃N₅

Purity: Min. 95%

Molecular weight: 381.5 g/mol

Ref: 3D-DQC50291